Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolates.

Antimicrobial agents and chemotherapy - 1 May 2012

Housman Seth T, Keel Rebecca A, Crandon Jared L, Williams Gregory, Nicolau David P

Abstract excerpt

Ceftaroline fosamil, a new broad-spectrum cephalosporin, exhibits potent bactericidal activity against common Gram-negative pathogens, including Enterobacteriaceae, and Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cephalosporins
Share to Enterobacteriaceae
Share to Enterobacteriaceae Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunocompetence

Share to Injections, Intravenous

Share to Klebsiella

Share to Mice, Inbred ICR

Share to Neutropenia

Source

Open in PubMed Open full text

Identifiers

PMID: 22330908
DOI: 10.1128/AAC.06416-11
PMCID: PMC3346611

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22330908-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolates.PMID 22330908Read ↗

Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates.Semantic proximity Read ↗

In Vivo Efficacy of Humanized Exposures of Ceftazidime-Avibactam in Comparison with Ceftazidime against Contemporary Enterobacteriaceae IsolatesSemantic proximity Read ↗

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection ModelSemantic proximity Read ↗

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activitySemantic proximity Read ↗

In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.Semantic proximity Read ↗

Ceftaroline fosamil in the treatment of experimental meningitis caused by methicillin-resistant Staphylococcus aureusSemantic proximity Read ↗

In vivopharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteriaSemantic proximity Read ↗

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.Semantic proximity Read ↗

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infectionsSemantic proximity Read ↗

Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosaSemantic proximity Read ↗

Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.Semantic proximity Read ↗

In Vivo Pharmacodynamic Activity of the Glycopeptide DalbavancinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.